_id
690daa5fccc777a4e85d08b8
Ticker
AEON
Name
AEON Biopharma, Inc.
Exchange
NYSE MKT
Address
5 Park Plaza, Irvine, CA, United States, 92614
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.aeonbiopharma.com
Description
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Last Close
1.12
Volume
71085
Current Price
1.2299
Change
0.0899
Last Updated
2026-01-20T14:48:19.926Z
Image
data:image/webp;base64,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
Ipo Date
2021-04-12T00:00:00.000Z
Market Cap
10945159
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
7.2
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2493000
Operating Income
-2493000
Interest Expense
-
Pretax Income
-4538000
Net Income
-4538000
Eps
-0.3900318918540748
Dividends Per Share
-
Shares Outstanding
11643786
Income Tax Expense
-
EBITDA
-2511000
Operating Margin
-
Total Other Income Expense Net
-2045000
Cash
5927000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
7412000
Property Plant Equipment
1293000
Total Assets
8734000
Payables
2525000
Short Term Debt
247000
Long Term Debt
17051000
Total Liabilities
28606000
Equity
-19872000
Bs_currency_symbol
USD
Depreciation
19000
Change In Working Capital
814000
Cash From Operations
-2596000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
84000
Net Change In Cash
-2512000
Cf_currency_symbol
USD
PE
-
PB
-0.7200996419786635
ROE
22.836151368760063
ROA
-51.9578658117701
FCF
-2596000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
6
Net Net Investing Score
1.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2493000
Quarters > 0 > income Statement > operating Income
-2493000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4538000
Quarters > 0 > income Statement > net Income
-4538000
Quarters > 0 > income Statement > eps
-0.3900318918540748
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
11634946
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2511000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-2045000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
5927000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7412000
Quarters > 0 > balance Sheet > property Plant Equipment
1293000
Quarters > 0 > balance Sheet > total Assets
8734000
Quarters > 0 > balance Sheet > payables
2525000
Quarters > 0 > balance Sheet > short Term Debt
247000
Quarters > 0 > balance Sheet > long Term Debt
17051000
Quarters > 0 > balance Sheet > total Liabilities
28606000
Quarters > 0 > balance Sheet > equity
-19872000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-4538000
Quarters > 0 > cash Flow > depreciation
19000
Quarters > 0 > cash Flow > change In Working Capital
814000
Quarters > 0 > cash Flow > cash From Operations
-2596000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
84000
Quarters > 0 > cash Flow > net Change In Cash
-2512000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.3900318918540748
Quarters > 0 > ratios > PB
-0.7200996419786635
Quarters > 0 > ratios > ROE
22.836151368760063
Quarters > 0 > ratios > ROA
-51.9578658117701
Quarters > 0 > ratios > FCF
-2596000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
4338000
Quarters > 1 > income Statement > operating Income
-4338000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6642000
Quarters > 1 > income Statement > net Income
-6642000
Quarters > 1 > income Statement > eps
-0.5988742570537461
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
11090809
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4302000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-2304000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
8439000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10262000
Quarters > 1 > balance Sheet > property Plant Equipment
1371000
Quarters > 1 > balance Sheet > total Assets
11662000
Quarters > 1 > balance Sheet > payables
3907000
Quarters > 1 > balance Sheet > short Term Debt
242000
Quarters > 1 > balance Sheet > long Term Debt
15174000
Quarters > 1 > balance Sheet > total Liabilities
27514000
Quarters > 1 > balance Sheet > equity
-15852000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6642000
Quarters > 1 > cash Flow > depreciation
20000
Quarters > 1 > cash Flow > change In Working Capital
537000
Quarters > 1 > cash Flow > cash From Operations
-2091000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
84000
Quarters > 1 > cash Flow > net Change In Cash
-2007000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5988742570537461
Quarters > 1 > ratios > PB
-0.8604962143010346
Quarters > 1 > ratios > ROE
41.9000757002271
Quarters > 1 > ratios > ROA
-56.95421025553078
Quarters > 1 > ratios > FCF
-2091000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
462000
Quarters > 2 > income Statement > operating Income
-462000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
9095000
Quarters > 2 > income Statement > net Income
9095000
Quarters > 2 > income Statement > eps
2.282379677560858
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3984876
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3931000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
9557000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10446000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
12321000
Quarters > 2 > balance Sheet > property Plant Equipment
1449000
Quarters > 2 > balance Sheet > total Assets
13799000
Quarters > 2 > balance Sheet > payables
2437000
Quarters > 2 > balance Sheet > short Term Debt
197000
Quarters > 2 > balance Sheet > long Term Debt
13320000
Quarters > 2 > balance Sheet > total Liabilities
25122000
Quarters > 2 > balance Sheet > equity
-11323000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
9095000
Quarters > 2 > cash Flow > depreciation
19000
Quarters > 2 > cash Flow > change In Working Capital
-5810000
Quarters > 2 > cash Flow > cash From Operations
-7909000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
-4000
Quarters > 2 > cash Flow > cash From Financing
18346000
Quarters > 2 > cash Flow > net Change In Cash
10433000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
2.282379677560858
Quarters > 2 > ratios > PB
-0.43283573190850483
Quarters > 2 > ratios > ROE
-80.32323589154817
Quarters > 2 > ratios > ROA
65.9105732299442
Quarters > 2 > ratios > FCF
-7913000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
47
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2321000
Quarters > 3 > income Statement > operating Income
-2321000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
2082000
Quarters > 3 > income Statement > net Income
2082000
Quarters > 3 > income Statement > eps
3.749027629721398
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
555344
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5643000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
4403000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
13000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1590000
Quarters > 3 > balance Sheet > property Plant Equipment
1523000
Quarters > 3 > balance Sheet > total Assets
3142000
Quarters > 3 > balance Sheet > payables
5910000
Quarters > 3 > balance Sheet > short Term Debt
121000
Quarters > 3 > balance Sheet > long Term Debt
11689000
Quarters > 3 > balance Sheet > total Liabilities
31711000
Quarters > 3 > balance Sheet > equity
-28569000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
2082000
Quarters > 3 > cash Flow > depreciation
23000
Quarters > 3 > cash Flow > change In Working Capital
3295000
Quarters > 3 > cash Flow > cash From Operations
-621000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
97000
Quarters > 3 > cash Flow > net Change In Cash
-524000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
3.749027629721398
Quarters > 3 > ratios > PB
-0.023907647646049912
Quarters > 3 > ratios > ROE
-7.28761944765305
Quarters > 3 > ratios > ROA
66.26352641629535
Quarters > 3 > ratios > FCF
-621000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-72985000
Annuals > 0 > income Statement > operating Income
72985000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
42005000
Annuals > 0 > income Statement > net Income
42005000
Annuals > 0 > income Statement > eps
72.93231124499735
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
575945
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-27727000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-30980000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
13000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1590000
Annuals > 0 > balance Sheet > property Plant Equipment
1523000
Annuals > 0 > balance Sheet > total Assets
3142000
Annuals > 0 > balance Sheet > payables
5910000
Annuals > 0 > balance Sheet > short Term Debt
121000
Annuals > 0 > balance Sheet > long Term Debt
11689000
Annuals > 0 > balance Sheet > total Liabilities
31711000
Annuals > 0 > balance Sheet > equity
-28569000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
42005000
Annuals > 0 > cash Flow > depreciation
97000
Annuals > 0 > cash Flow > change In Working Capital
706000
Annuals > 0 > cash Flow > cash From Operations
-20292000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
15147000
Annuals > 0 > cash Flow > net Change In Cash
-5145000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
72.93231124499735
Annuals > 0 > ratios > PB
-0.02479452397703805
Annuals > 0 > ratios > ROE
-147.02999754979174
Annuals > 0 > ratios > ROA
1336.8873329089752
Annuals > 0 > ratios > FCF
-20292000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
348086000
Annuals > 1 > income Statement > operating Income
-348086000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-384632000
Annuals > 1 > income Statement > net Income
-384632000
Annuals > 1 > income Statement > eps
-4.990514270580507
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
77072618
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-52737000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-36546000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
5158000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
6222000
Annuals > 1 > balance Sheet > property Plant Equipment
594000
Annuals > 1 > balance Sheet > total Assets
6845000
Annuals > 1 > balance Sheet > payables
3388000
Annuals > 1 > balance Sheet > short Term Debt
278000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
159889000
Annuals > 1 > balance Sheet > equity
-153044000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-384632000
Annuals > 1 > cash Flow > depreciation
99000
Annuals > 1 > cash Flow > change In Working Capital
-2739000
Annuals > 1 > cash Flow > cash From Operations
-47825000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
14000000
Annuals > 1 > cash Flow > net Change In Cash
-4588000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-4.990514270580507
Annuals > 1 > ratios > PB
-0.6193749044601553
Annuals > 1 > ratios > ROE
251.32118867776586
Annuals > 1 > ratios > ROA
-5619.167275383492
Annuals > 1 > ratios > FCF
-47825000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
39
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
48429000
Annuals > 2 > income Statement > operating Income
-48429000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-52556000
Annuals > 2 > income Statement > net Income
-52556000
Annuals > 2 > income Statement > eps
-27.25301758357891
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1928447
Annuals > 2 > income Statement > income Tax Expense
-160485
Annuals > 2 > income Statement > EBITDA
-48361000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-4127000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9746000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
9838000
Annuals > 2 > balance Sheet > property Plant Equipment
906000
Annuals > 2 > balance Sheet > total Assets
10778000
Annuals > 2 > balance Sheet > payables
7805000
Annuals > 2 > balance Sheet > short Term Debt
71123000
Annuals > 2 > balance Sheet > long Term Debt
60426000
Annuals > 2 > balance Sheet > total Liabilities
281191000
Annuals > 2 > balance Sheet > equity
-287500000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-52556000
Annuals > 2 > cash Flow > depreciation
68000
Annuals > 2 > cash Flow > change In Working Capital
6268000
Annuals > 2 > cash Flow > cash From Operations
-35584000
Annuals > 2 > cash Flow > capital Expenditures
306000
Annuals > 2 > cash Flow > cash From Investing
-306000
Annuals > 2 > cash Flow > cash From Financing
40508000
Annuals > 2 > cash Flow > net Change In Cash
4618000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-27.25301758357891
Annuals > 2 > ratios > PB
-0.008249728574956521
Annuals > 2 > ratios > ROE
18.280347826086956
Annuals > 2 > ratios > ROA
-487.62293560957505
Annuals > 2 > ratios > FCF
-35890000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
28
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
65847000
Annuals > 3 > income Statement > operating Income
-65847000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-55637000
Annuals > 3 > income Statement > net Income
-55637000
Annuals > 3 > income Statement > eps
-31.72895035041166
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1753509
Annuals > 3 > income Statement > income Tax Expense
28966000
Annuals > 3 > income Statement > EBITDA
-36878000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
10210000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5128000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
5154000
Annuals > 3 > balance Sheet > property Plant Equipment
922000
Annuals > 3 > balance Sheet > total Assets
6436000
Annuals > 3 > balance Sheet > payables
1192000
Annuals > 3 > balance Sheet > short Term Debt
15603000
Annuals > 3 > balance Sheet > long Term Debt
70762000
Annuals > 3 > balance Sheet > total Liabilities
230260000
Annuals > 3 > balance Sheet > equity
-234944000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-55637000
Annuals > 3 > cash Flow > depreciation
3000
Annuals > 3 > cash Flow > change In Working Capital
1416000
Annuals > 3 > cash Flow > cash From Operations
-28433000
Annuals > 3 > cash Flow > capital Expenditures
170000
Annuals > 3 > cash Flow > cash From Investing
-170000
Annuals > 3 > cash Flow > cash From Financing
13563000
Annuals > 3 > cash Flow > net Change In Cash
-15040000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-31.72895035041166
Annuals > 3 > ratios > PB
-0.009179381976556116
Annuals > 3 > ratios > ROE
23.68096227186053
Annuals > 3 > ratios > ROA
-864.4655065257924
Annuals > 3 > ratios > FCF
-28603000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.3900318918540748
Valuation > metrics > PB
-0.7200996419786635
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
22.836151368760063
Profitability > metrics > ROA
-61.225040474905555
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.2298963986186482
Risk > final Score
25
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.6738816738816737
Liquidity > metrics > Quick Ratio
2.6738816738816737
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
45
Prev Profitabilities > 2
45
Prev Risks > 0
23
Prev Risks > 1
30
Prev Risks > 2
29
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
23
Updated At
2026-01-20T21:20:30.885Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.39
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.39
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.6
Earnings History > 1 > eps Estimate
-0.35
Earnings History > 1 > eps Difference
-0.25
Earnings History > 1 > surprise Percent
-71.4286
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
2.28
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
3.47
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-11.52
Earnings History > 4 > eps Estimate
-11.52
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
5.3352
Earnings History > 5 > eps Estimate
-13.68
Earnings History > 5 > eps Difference
19.0152
Earnings History > 5 > surprise Percent
139
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.28
Earnings History > 6 > eps Estimate
-0.31
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
9.6774
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.71
Earnings History > 7 > eps Estimate
-0.4
Earnings History > 7 > eps Difference
-0.31
Earnings History > 7 > surprise Percent
-77.5
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
1.15
Earnings History > 8 > eps Estimate
-0.53
Earnings History > 8 > eps Difference
1.68
Earnings History > 8 > surprise Percent
316.9811
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-31.8849
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.399
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.1928
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
3.4277
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
3.8966
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
5.788
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2021-12-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.5173
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-10-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.66
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-1.66
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-06-30
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-8.4004
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAeon Biopharma stock falls after FDA meeting and debt restructuring Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7.2
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of AEON Biopharma, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.39
EPS Estimate
0
EPS Difference
-0.39
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.